NCT05739513View on ClinicalTrials.gov

A Specific miRNA Encoded by SARS-CoV-2 as a Diagnostic Tool to Predict Disease Severity in COVID-19 Patients

NACompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

December 7, 2020

Primary Completion Date

July 1, 2021

Study Completion Date

July 12, 2021

Conditions

COVID-19

Interventions

DIAGNOSTIC_TEST

miRNA analysis in plasma

blood sample

Trial Locations (1)

00168

Mingrone Geltrude, Roma

All Listed Sponsors

lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

NCT05739513 - A Specific miRNA Encoded by SARS-CoV-2 as a Diagnostic Tool to Predict Disease Severity in COVID-19 Patients | Biotech Hunter | Biotech Hunter